Who bears the costs of anti-depressants in Australia?
dc.contributor.author | Goldney, R. | |
dc.date.issued | 1995 | |
dc.identifier.citation | Medical Journal of Australia, 1995; 162(162):162- | |
dc.identifier.doi | 10.5694/j.1326-5377.1995.tb138485.x | |
dc.identifier.issn | 0314-514X | |
dc.identifier.issn | 1326-5377 | |
dc.identifier.uri | http://hdl.handle.net/2440/6553 | |
dc.language.iso | en | |
dc.publisher | Medical Publishing Co. | |
dc.source.uri | https://doi.org/10.5694/j.1326-5377.1995.tb138485.x | |
dc.subject | Humans | |
dc.subject | Antidepressive Agents | |
dc.subject | Cost-Benefit Analysis | |
dc.subject | Drug Costs | |
dc.subject | Australia | |
dc.subject | Drug Overdose | |
dc.title | Who bears the costs of anti-depressants in Australia? | |
dc.type | Journal article | |
pubs.publication-status | Published |